Future developments in hormonal contraception

American Journal of Obstetrics and Gynecology

Volumn 190, Issue 4 SUPPL., 2004, Pages

  Johansson, Elof D B ^a  

^a POPULATION COUNCIL   (United States)

Author keywords

Contraceptive ring; Intrauterine system; Long term contraceptives; Subdermal implants; Transdermal patch

Indexed keywords

CONTRACEPTIVE AGENT; ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETHYLENE VINYL ACETATE COPOLYMER; ETONOGESTREL; GESTAGEN; LEVONORGESTREL;

DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG RESEARCH; DYSMENORRHEA; HORMONAL CONTRACEPTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; OVULATION INHIBITION; PREGNANCY RATE; PRIORITY JOURNAL; SHORT SURVEY; VAGINA RING;

EID: 2342445745     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.01.059     Document Type: Article

References (18)

1. Rosenberg MJ, Waugh MS. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 1998;179(3 Pt 1):577-82.
2. United Nations. Levels and trends of contraceptive use as assessed in 1998. New York: Department for Economic and Social Affairs, Population Division, United Nations; 1999(a).
3. Stover J, Ross JA, Willard A. Profiles for family planning and reproductive health programs: 116 countries. Glastonbury (CT): The Futures Group International; 1999.
4. United Nations. World population prospects: the 1998 revision. Volume I: comprehensive tables. New York: Department for Economic and Social Affairs, Population Division, United Nations; 1999(b).
5. Women want birth control that simplifies their lives [press release]. Alexandria, Va American Medical Women's Association; November 1, 2001.
6. Lunelle [package insert]. Peapack, NJ: Pharmacia Corp; 1999.
7. Andersson K, Rybo G. Levonorgestrel-releasing intrauterine system in the treatment of menorrhagia. BJOG 1990;97:690-4.
8. Istre O, Trolle B. Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection. Fertil Steril 2001;76:304-9.
9. Lethaby AE, Cooke I, Rees M. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding. Cochrane Database Syst Rev 2000;2:CD002126.
10. Ruusuvaara L, Johansson ED. Contraceptive strategies for young women in the 21st century. Eur J Contracept Reprod Health Care 1999;4:255-63.
11. Makäräinen L, van Beek A, Tuomivaara L, Asplund B, Coelingh Bennink H. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant. Fertil Steril 1998;69:714-21.
12. Roumen FJ, Apter D, Mulders TM, Dieben TO. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl estradiol. Hum Reprod 2001;16:469-75.
13. Abrams LS, Skee D, Natarajan J, Wong FA. Pharmacokinetic overview of Ortho Evra/Evra. Fertil Steril 2002;77(Suppl 2):S3-12.
14. Titia M, Mulders T, Dieben TOM. Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition. Fertil Steril 2001;75:865-70.
15. Sibai BM, Odlind V, Meador ML, Shangold GA, Fisher AC, Creasy GW. A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra). Fertil Steril 2002;77(Suppl 2):S9-26.
16. Hatcher RA, Trussell J, Stewart F, et al. Contraceptive technology. 17th rev ed. New York: Ardent Media Inc; 1998.
17. Bongaartz J. Trends in unwanted childbearing in the developing world. Stud Fam Plann 1997;28:267-77.
18. Alan Guttmacher Institute. Fulfilling the promise: public policy and U.S. family planning clinics. New York: AGI; 2000.